Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01915498
Brief Title: Phase 1/2 Study of Enasidenib (AG-221) in Adults With Advanced Hematologic Malignancies With an Isocitrate Dehydrogenase Isoform 2 (IDH2) Mutation

First Submitted : July 31, 2013
First Submitted that Met QC Criteria : August 1, 2013
First Posted : August 5, 2013 (Estimate)

Results First Submitted : July 25, 2020
Results First Submitted that Met QC Criteria : October 1, 2020
Results First Posted : October 23, 2020

Last Update Submitted that Met QC Criteria : October 1, 2020
Last Update Posted : October 23, 2020